학술논문
Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation.
Document Type
Article
Author
Source
Cell Death & Disease; Sep2022, Vol. 13 Issue 9, p1-12, 12p
Subject
Language
ISSN
20414889